1 Result for "

osteolytic malignant bone lesions

" in MedChemExpress (MCE) Product Catalog:
Products (1)

1 Results for "osteolytic malignant bone lesions" in MCE Product Catalog:

  • Oligonucleotides Recommended:
3
3 Cited Publications
Cat. No.: HY-18664
CAS No.: 900305-37-5
Research Areas:  

Cancer

PFI-4 (compound 11), a chemical probe, is a potent and highly selective BRPF1 Bromodomain (BRPF1B) inhibitor, with an IC50 of 172 nM. PFI-4 can be used to explore the functional mechanisms of the HBO1/BRPF1 complex and to study bone loss and osteolytic malignant bone lesions .
loading...
    loading...